SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-23-129009
Filing Date
2023-12-26
Accepted
2023-12-26 08:39:37
Documents
8

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm2332950d2_defa14a.htm DEFA14A 58042
2 EXHIBIT 2.1 tm2332950d2_ex2-1.htm EX-2.1 496586
3 EXHIBIT 10.1 tm2332950d2_ex10-1.htm EX-10.1 71001
4 EXHIBIT 10.2 tm2332950d2_ex10-2.htm EX-10.2 17692
5 EXHIBIT 10.3 tm2332950d2_ex10-3.htm EX-10.3 17419
6 EXHIBIT 10.4 tm2332950d2_ex10-4.htm EX-10.4 17688
7 EXHIBIT 99.1 tm2332950d2_ex99-1.htm EX-99.1 13928
8 GRAPHIC tm2332950d2_ex99-1img001.jpg GRAPHIC 14719
  Complete submission text file 0001104659-23-129009.txt   713834
Mailing Address 835 INDUSTRIAL ROAD, SUITE 400 SAN CARLOS CA 94070
Business Address 835 INDUSTRIAL ROAD, SUITE 400 SAN CARLOS CA 94070 650-595-2595
Atreca, Inc. (Filer) CIK: 0001532346 (see all company filings)

IRS No.: 273723255 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38935 | Film No.: 231511424
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)